BACKGROUND: In HIV-1-infected women, poor micronutrient status has been associated with faster progression of HIV-1 disease and adverse birth outcomes. We assessed the effects of vitamin A and multivitamins on birth outcomes in such women. METHODS: In Tanzania, 1075 HIV-1-infected pregnant women at between 12 and 27 weeks' gestation receivedplacebo (n=267), vitamin A (n=269), multivitamins excluding vitamin A (n=269), or multivitamins including vitamin A (n=270) in a randomised, double-blind, placebo-controlled trial with a 2x2 factorial design. We measured the effects of multivitamins and vitamin A on birth outcomes and counts of T lymphocyte subsets. We did analyses by intention to treat. RESULTS:30 fetal deaths occurred among women assigned multivitamins compared with 49 among those not on multivitamins (relative risk 0.61 [95% CI 0.39-0.94] p=0.02). Multivitamin supplementation decreased the risk of low birthweight (<2500 g) by 44% (0.56 [0.38-0.82] p=0.003), severe preterm birth (<34 weeks of gestation) by 39% (0.61 [0.38-0.96] p=0.03), and small size for gestational age at birth by 43% (0.57 [0.39-0.82] p=0.002). Vitamin A supplementation had no significant effect on these variables. Multivitamins, but not vitamin A, resulted in a significant increase in CD4, CD8, and CD3 counts. INTERPRETATION:Multivitamin supplementation is a low-cost way of substantially decreasing adverse pregnancy outcomes and increasing T-cell counts in HIV-1-infected women. The clinical relevance of our findings for vertical transmission and clinical progression of HIV-1 disease is yet to be ascertained.
RCT Entities:
BACKGROUND: In HIV-1-infectedwomen, poor micronutrient status has been associated with faster progression of HIV-1 disease and adverse birth outcomes. We assessed the effects of vitamin A and multivitamins on birth outcomes in such women. METHODS: In Tanzania, 1075 HIV-1-infected pregnant women at between 12 and 27 weeks' gestation received placebo (n=267), vitamin A (n=269), multivitamins excluding vitamin A (n=269), or multivitamins including vitamin A (n=270) in a randomised, double-blind, placebo-controlled trial with a 2x2 factorial design. We measured the effects of multivitamins and vitamin A on birth outcomes and counts of T lymphocyte subsets. We did analyses by intention to treat. RESULTS: 30 fetal deaths occurred among women assigned multivitamins compared with 49 among those not on multivitamins (relative risk 0.61 [95% CI 0.39-0.94] p=0.02). Multivitamin supplementation decreased the risk of low birthweight (<2500 g) by 44% (0.56 [0.38-0.82] p=0.003), severe preterm birth (<34 weeks of gestation) by 39% (0.61 [0.38-0.96] p=0.03), and small size for gestational age at birth by 43% (0.57 [0.39-0.82] p=0.002). Vitamin A supplementation had no significant effect on these variables. Multivitamins, but not vitamin A, resulted in a significant increase in CD4, CD8, and CD3 counts. INTERPRETATION: Multivitamin supplementation is a low-cost way of substantially decreasing adverse pregnancy outcomes and increasing T-cell counts in HIV-1-infectedwomen. The clinical relevance of our findings for vertical transmission and clinical progression of HIV-1 disease is yet to be ascertained.
Entities:
Keywords:
Acquired Immunodeficiency Syndrome--women; Africa; Africa South Of The Sahara; Biology; Birth Weight; Body Weight; Correlation Studies; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Fetal Death; Food Supplementation; Health; Health Services; Hiv Infections--women; Low Birth Weight; Mortality; Nutrition Programs; Physiology; Population; Population Characteristics; Population Dynamics; Pregnancy; Pregnancy Outcomes; Pregnant Women; Premature Birth; Primary Health Care; Reproduction; Research Methodology; Research Report; Statistical Studies; Studies; Tanzania; Viral Diseases; Vitamin A; Vitamins
Authors: K Castetbon; O Manigart; D Bonard; M J Thomas; M F Dumon; D Malvy; P Van de Perre; F Dabis Journal: AIDS Date: 2000-05-05 Impact factor: 4.177
Authors: A Kassu; A Tsegaye; B Petros; D Wolday; E Hailu; T Tilahun; B Hailu; M T Roos; A L Fontanet; D Hamann; T F De Wit Journal: Clin Diagn Lab Immunol Date: 2001-11
Authors: K P West; J Katz; S K Khatry; S C LeClerq; E K Pradhan; S R Shrestha; P B Connor; S M Dali; P Christian; R P Pokhrel; A Sommer Journal: BMJ Date: 1999-02-27
Authors: Valerie L Flax; Linda S Adair; Lindsay H Allen; Setarah Shahab-Ferdows; Daniela Hampel; Charles S Chasela; Gerald Tegha; Eric J Daza; Amanda Corbett; Nicole L Davis; Deborah Kamwendo; Athena P Kourtis; Charles M van der Horst; Denise J Jamieson; Margaret E Bentley Journal: J Nutr Date: 2015-07-08 Impact factor: 4.798
Authors: Christine M McDonald; Karim P Manji; Roland Kupka; David C Bellinger; Donna Spiegelman; Rodrick Kisenge; Gernard Msamanga; Wafaie W Fawzi; Christopher P Duggan Journal: J Nutr Date: 2012-12-19 Impact factor: 4.798
Authors: Tracie L Miller; Carlo Agostoni; Christopher Duggan; Alfredo Guarino; Mark Manary; Carlos A Velasco Journal: J Pediatr Gastroenterol Nutr Date: 2008-08 Impact factor: 2.839
Authors: Christopher R Sudfeld; Ashley Buchanan; Nzovu Ulenga; Donna Spiegelman; Expeditho Mtisi; Ellen Hertzmark; Aisa N Muya; David Sando; Ester Mungure; Mucho Mizinduko; Wafaie W Fawzi Journal: AIDS Date: 2019-01-27 Impact factor: 4.177